Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Mental health care is experiencing a breakthrough with Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive and drug-free treatment providing hope for individuals battling depression, ...

BrainsWay Deep TMS is not currently cleared by the FDA for the safe or effective treatment of neuropathic pain. Additional outcomes from research conducted on these and other neuropathic pain patients ...

Ltd. has announced the publication of Phase 2a clinical trial results for JX10 (TMS-007), a potential treatment for acute ischemic stroke, in a leading medical journal. The study demonstrated ...

BrainsWay (BWAY) announced the publication of positive feasibility clinical data evaluating the analgesic effects of deep transcranial magnetic ...

Results showed that Active deep-TMS therapy significantly reduced "usual pain intensity" in patients with chronic peripheral neuropathic pain compared to sham treatment and improved symptoms of ...

Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of 2024, amid ...